OOIR: Observatory of International Research

Papers

(The median citation count of BJU International is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Reply to ‘Comment on Bertini et al.: area deprivation and PSA screening disparities’ and ‘Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivati	119
Response to Chen et al.	96
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer	79
The European Association of Urology talent incubator: bridging competencies for holistic urological care	79
	64
April's reviewers of the month	63
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial	62
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension	57
Recent key papers in prostate cancer	54
The LANDMARK project: providing summaries of key papers that have shaped urological practice	51
Editorial Board	51
	46
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?	46
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer	46
Author Index	44
September's reviewers of the month	43
Eve's and Adam's rib for prostate cancer screening	42
MRI , Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?	42
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.3	39
Editorial Board	38
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes	37
MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses	35
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents	34
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?	33
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis	32

ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing	31
Frail and forgotten: an EAU YAU call for trainee‐led research on frailty in urology	31
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial	30
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?	29
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold	29
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography ( PSMA‐PET) and magnetic resonance imaging (	28
Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study	28
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	28
Sexual function in adolescence after childhood hypospadias repair: a patient‐reported outcome study	27
Response to comments on ‘Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy’	26
Issue Information	26
Response to comment by Semwal et al.	26
Benchtop comparison of seven ureteroscopes: evaluating physical properties and deflection with flexible and navigable suction access sheaths	26
Comment on: ‘Residents surgical training using metrics for transurethral resection of bladder tumours’	24
Defining a new national undergraduate urology curriculum in the UK using consensus‐based methodology	24
Building a research profile during residency	24
Beyond pass or fail: Enhancing the rigour in urological artificial intelligence examination assessment	23
The rapid assessment for prostate imaging and diagnosis ( RAPID ) prostate cancer diagnostic pathway	23
Patient‐side performance metrics and errors in robotic surgery: Junior‐ European Association of Urology Robotic Urology Section/Young Academic Urologists (J‐ ERUS	23
	23
Ureterorenoscopy during normothermic machine perfusion: effect of varying renal pelvis pressure	23
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	22
Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial	22
Preferences between three options for androgen deprivation therapy: a focus group study	22
Reply to ‘Comment on novel MRI ‐ US fusion with advanced annotation in focal cryoablation for pros	22
Can only AI save us from the burden of administration?	22
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study	22
Table of Contents	21
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours	21
August's reviewers of the month	21
Reply to ‘A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer’ by Su et al.	21
	21
Caval thrombectomy a urological leap into the unknown – a call for action	21
Thulium fibre laser lithotripsy, the new standard?	21
	21
Progress in the management of stone disease	21
September's reviewers of the month	20
Issue Information	20
How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway	20
Why prompting matters: achieving clinically accurate and consistent responses with Chat GPT	20
Is Gleason 6 cancer? The answer is more than just a ‘name’	20
The effect of different assays on prostate‐specific antigen testing	19
Can exercise increase natural killer cell infiltration of the prostate?	19
Correction to “Outcomes of BCG vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer”	19
Editorial Board	19
Area deprivation and cancer‐specific mortality in non‐muscle‐invasive bladder cancer: a statewide analysis	18
Prediction Analysis of Microarray of 50 genes ( PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami	18
Guideline of guidelines: Peyronie's disease	18
Sustainability in urology – are we doing enough?	18
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients	17

Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge	17
A meta‐analysis of Retzius‐sparing and hood‐technique robot‐assisted radical prostatectomy	17
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy	17
Non‐significant does not mean uninformative – but poor reporting can be misleading	17
Artificial intelligence‐based approaches to augmenting and automating surgical training	16
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery	16
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor	16
Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter	16
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function	16
Correction to ‘Complications of vasectomy: results from a prospective audit of 105 393 procedures’	16
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐ less	16
The prostate cancer electronic health ( eHealth) literacy instrument: a tool for eHealth design an	16
Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults	16
Response to: ‘Balancing sheath–scope size in flexible ureteroscopy’	16
Vascular closure devices in living‐donor nephrectomy: a much‐needed systematic review and meta‐analysis focusing on safety	16
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication	15
Comment on ‘Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management’	15
Development of an optically transparent kidney model for laser lithotripsy research	15
Issue Information	15
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease	15
Ureteric stenting after uncomplicated ureteroscopy: a systematic review of surgeons’ motivations and patient experiences	15
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer	15
Evaluating the predictors of poor corporal integrity in penile implant recipients	15
Response to Zhu et al.	15
	15
Editorial Board	14
Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users	14
Re‐defining the interpretation of 24‐h urine studies for stone formers	14
Cystectomy and lymphadenectomy – we now node how far to go!	14
Editorial Board	14
Editorial Board	14
	14
Journal information	14
	14
The importance of the urologist in male oncology fertility preservation	14
Issue Information	14
Journal information	14
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia	13
Scribe smarter, not harder: how artificial intelligence scribes stack up against human clinicians	13
	13
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone‐sensitive prostate cancer	13
Long‐term outcomes of cribriform‐positive and cribriform‐negative prostate cancer treated with radical prostatectomy in the ProtecT trial	13
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients	13
Definitive local therapy for T4 prostate cancer associated with improved local control and survival	13
Deep learning‐based classification of acute scrotum using single ultrasound images	13
Key ingredients for running a randomised controlled trial in a surgical day unit	13
Clinical presentation of bacille Calmette–Guérin ( BCG ) infections after	13
Developing an artificial intelligence model for phase recognition in robot‐assisted radical prostatectomy	13
‘ Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and ne	13
Functional outcomes of robot‐assisted partial nephrectomy in patients with a solitary kidney	13
Single‐port robot‐assisted nephroureterectomy via a supine anterior approach: step‐by‐step technique	13
An MRI/PET PSMA‐based phase I–II study of salvage high‐dose‐rate brachytherapy after surgery and radiotherapy	13
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’	13
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer	13
Hydraulic and malleable female‐to‐male penile implants after phalloplasty in transgender individuals: a retrospective cohort analysis	13
First‐line programmed death receptor‐1 ( PD ‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemothe	12
November's reviewers of the month	12
Neural monitoring of central responses to lower urinary tract function	12
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?	12
Revisiting patient selection and treatment planning in the VIOLETTE trial of targeted microwave ablation	12
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study	12
Focal therapy using a novel cooled laser device for prostate cancer: early trial results	12
‘ BJUI Clinical Dilemma’: Recurrent high‐grade non‐muscle‐invasive bladder cancer in 2026	12
There is more to disposable endoscopes than whether they work…	12
Use of a microdebrider for epithelial excision during vaginectomy/colpocleisis in patients undergoing metoidioplasty	12
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function	12
Greenlight laser prostatectomy: which goggles are best for visualising haematuria accurately?	12
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging	12
Alternate‐day administration of intravesical gemcitabine and docetaxel to improve clinic utilisation	12
Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?	12
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial	12
Outcomes after laser enucleation of the prostate with and without significant storage symptoms	12
Perspectives on technology: Single‐use catheters – evidence and environmental impact	12
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy	12
Complete response in metastatic renal cell carcinoma: impact of a persistent primary lesion	11
Table of Contents	11
Recovery and immune function after low pressure pneumoperitoneum during robot‐assisted radical prostatectomy: a randomised controlled trial	11
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups	11
Google infodemiology and temporal trends in benign prostatic hyperplasia surgery in Australia	11
Response to ‘Comment on robot‐assisted partial nephrectomy using the Hugo™ RAS system: first multicentre study’	11

Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three‐dimensional transrectal ultrasonography segmentation	11
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐	11
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review	11
Cisplatin‐ineligible patients with muscle‐invasive bladder cancer demonstrate poor long‐term survival following immediate radical cystectomy	11
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis	11
Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population‐based study	11
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma	10
Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study	10
Fluid management and suction in endourology	10
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer	10
Catheterisation after urethral lengthening in transgender/gender‐diverse individuals: a randomised controlled trial (Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction [	10
F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer	10
Issue Information	10
The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer	10
Iatrogenic ureteric injuries after abdominal surgery: a systematic review and meta‐regression from the European Association of Urology Endourology Section	10
Oncological outcomes after attempted nerve‐sparing radical prostatectomy (NSRP) in patients with high‐risk prostate cancer are comparable to standard non‐NSRP: a longitudinal long‐term propensity‐matc	10
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours	10
Recommendation on the use of protective eyewear in endourological laser procedures	10
Stone volume instead of maximum stone diameter: results from an international survey	10
Comment on ‘Can ChatGPT pass the urology fellowship examination? Artificial intelligence capability in surgical training assessment’	10
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade	9
Stapled vs totally handsewn robotic intracorporeal neobladder: perioperative and functional outcomes	9
Economic analysis of minimally invasive surgical treatments for BPH in the Australian public healthcare system	9
June's reviewers of the month	9
The first step in shared decision‐making for prostate cancer screening	9
Editorial Board	9
A novel two‐stage approach to the treatment of renal cell carcinoma with intra‐cardiac tumour extension and Budd–Chiari syndrome	9
A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer	9
Re: ‘The perioperative outcomes of papillary versus non‐papillary access in percutaneous nephrolithotomy’	9
	9
Issue Information	9
Editorial Board	9
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis	9
Retzius‐sparing robot‐assisted radical prostatectomy in renal transplant recipients	9
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer	9
Response to Daungsupawong and Wiwanitkit: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2	9
Big trials in prostate cancer \| predicting drug response in bladder cancer \| immune checkpoint inhibitors for urothelial carcinoma \| hydrochlorothiazide in the prevention of kidney stone recurrence	9
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort	9
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’	9
Deep‐learning segmentation to guide bladder neck recognition in robot‐assisted radical prostatectomy	9
Systematic review of PSA reference intervals in the gender diverse population with prostates	9
Real‐world outcomes for high‐risk non‐muscle‐invasive bladder cancer: screened patients for the BRAVO trial	9
Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy	8
August's reviewers of the month	8
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer	8
	8
Keith Kirkland Presentation	8
Novel bioabsorbable, low‐dose rate brachytherapy device (CivaSheet ^® ) with radical prostatectomy and adjuvant externa	8
Journal information	8
Robot‐assisted single‐port transvesical enucleation of the prostate: step‐by‐step technique and early single‐centre experience	8
May's reviewers of the month	8
Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer	8
Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial	8
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during	8
Villis Marshall Presentation	8
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy	8
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’	8
Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency	8
Trends in treatment and survival of older vs younger patients with renal cancer between 2011 and 2022	8
What are we missing? Identifying clinically significant prostate cancer among patients with low PSA : the utility of the free‐to‐total	8
Impact of perioperative nutrition on recovery after radical cystectomy: a randomised trial	8
Concurrent Session Presentations	8
	8
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical prediction	8
Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses	8
The role of testicular ultrasonography as a screening tool for testicular dysfunction in hypospadias	7
Is solo indocyanine green‐guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?	7
Prognostic impact of histological discordance between transurethral resection and radical cystectomy	7
B ladder‐centric benign prostatic hyperplasia management post‐laser enucleation of the prostate	7
Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy	7
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer	7
Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomy	7
Is genetic testing coming of age in advanced prostate cancer?	7
Response to Tang et al. ‘Evaluating the efficacy of physiotherapy in post‐prostatectomy continence and pelvic muscle function’	7
Impact of audit and feedback on transurethral resection of bladder tumour quality: a monocentric post‐completion evaluation of the RESECT trial	7
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy	7
Perspectives on technology: All STEPS count – an integrated framework for net zero urological care	7
Is analgesic efficacy of rectus sheath catheter actually non‐inferior to thoracic epidural catheter?	7
Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury	7
Cystoscopic application of RADA16 peptide for refractory haematuria from radiation cystitis	7
Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft	7
Table of Contents	7
Conservative management in high‐grade renal trauma: a systematic review and meta‐analysis	7
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management	7
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time	7
Alternatives to radical cystectomy: a bladder‐sparing approach in appropriately selected patients	7
Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care	7
Post‐prostatectomy anastomotic stenosis: systematic review and meta‐analysis of endoscopic treatment	7
Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial	7
Use of bulbospongiosus muscle for repair of traumatic posterior urethral stenosis combined with urethrorectal fistulas	7
Table of Contents	7
	7
Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta‐analysis	7
Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer	7
Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta‐analysis	7